CompletedNot Applicable

Comparison of Quality of Recovery Between Remimazolam and Propofol Anesthesia in Patients Undergoing Arthroscopic Meniscectomy

South Korea80 participantsStarted 2022-03-14

Plain-language summary

This study aims to compare quality of recovery after surgery and anesthesia between patients undergoing arthroscopic meniscectomy under general anesthesia with either propofol or remimazolam based total intravenous anesthesia. This study is a randomized trial with a 50% probability of being assigned to either group. Randomization will be done by an anesthesiologist not involved in anesthesia or postoperative outcome assessment. Patients and the investigator in charge of postoperative outcomes assessment will be blinded to group allocation.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients 19 or older, ASA class I\~III, * scheduled for arthroscopic meniscectomy under general anesthesia and eligible for LMA use. Exclusion Criteria: * Patient refusal, * patients unable to read consent form, active URI or uncontrolled asthma, * pneumonia, * history of allergies to propofol or benzodiazepines, * decreased liver or kidney function, heart failure of ejection fraction\<55%, * pregnant or breastfeeding patients, * history of substance abuse/addiction

What they're measuring

Quality of Recovery (QoR)-40 questionnaire

Timeframe: Postoperative 24 hours

Trial details

NCT IDNCT05280236

SponsorYonsei University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04-30

View on ClinicalTrials.gov More Adult Patients 19 or Older Scheduled for Elective Arthroscopic Meniscectomy trials